Lanxess AG · XETR:LXS

Lanxess — FY2005 Earnings Presentation

54 slides from Lanxess's earnings presentation, April 2006

  1. Slide 1: LANXESS - FY 2005 Results Roadshow: Independence Paying Off

    LANXESS - FY 2005 Results Roadshow Independence Paying Off April, 2006 April, 2006 FY 2005 Results Roadshow Chart-No. 1

  2. Slide 2: Safe Harbour Statement

    Safe Harbour Statement This Presentation contains certain forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, devel

  3. Slide 3: Agenda

    Agenda 1. 2005 Business Highlights and Strategy Review 2. FY 2005 Financials 3. Strategy Update 4. Outlook April, 2006 FY 2005 Results Roadshow Chart-No. 3

  4. Slide 4: Impressive Developments in 2005

    Impressive Developments in 2005 2005 EBITDA pre exceptionals increased by 30% Balance sheet structure and financial strength greatly improved Announced restructuring successfully initiated First portfolio adjustments completed Significant margin improvement with existing portfolio April, 2006 FY 200

  5. Slide 5: Step-by-Step Approach to Creating Value

    Step-by-Step Approach to Creating Value EBITDA* Short-term Mid-term Long-term margin 4. Acquisitions Portfolio > 10% Portfolio 3. adjustments 9-10% Targeted 2. restructuring Costs Performance 1. < 5% improvement Selective organic growth in profitable businesses * EBITDA pre exceptionals April, 2006

  6. Slide 6: Consistent Strategy Implementation

    Consistent Strategy Implementation 2005 First portfolio adjustments 9 4. Acquisitions - Paper and Fibers business units and iSL-Chemie divested to strategic Portfolio > 10% investors Portfolio 3. adjustments Targeted restructuring - Phase I: Styrenic Resins Europe and 9-10% 2. Targeted Fine Chemical

  7. Slide 7: Growth through Investment and Innovation

    Growth through Investment and Innovation 2005 Innovation 4. Acquisitions - Basic research replaced by targeted 9 research and development to open up Portfolio > 10% new applications and markets Portfolio 3. - Development work to optimize processes adjustments and costs 9-10% Targeted Investment 2. r

  8. Slide 8: EBITDA up 30% over 2004

    EBITDA up 30% over 2004 Sales EBITDA* Net income (€ bn) (€ m) (€ m) +5.6% 7.2 6.8 + 30.0% 581 447 Impacted by exceptionals 2004 2005 2004 2005 2004 2005 -12 EBITDA margin: -63 6.6% 8.1% * EBITDA pre exceptionals April, 2006 FY 2005 Results Roadshow Chart-No. 8

  9. Slide 9: Sales Growth mainly in Asia and Americas

    Sales Growth mainly in Asia and Americas Sales breakdown by region 2005 Regional sales development (€ m) + 20.6% 7,150 6.773 Germany 1,190 Asia 987 + 9.7% Asia 21% 17% Americas 1,757 1,928 + 3.1% Americas EMEA 2,419 2,494 27% (excl. Germany) - 4.5% EMEA (excl. Germany) 35% Germany 1,610 1,538 2004 2

  10. Slide 10: Agenda

    Agenda 1. 2005 Business Highlights and Strategy Review 2. FY 2005 Financials 3. Strategy Update 4. Outlook April, 2006 FY 2005 Results Roadshow Chart-No. 10

  11. Slide 11: Full Year 2005 Financial Highlights: Improved Performance and Sharply Reduced Net Debt

    Full Year 2005 Financial Highlights: Improved Performance and Sharply Reduced Net Debt (€ m) FY 2004 FY 2005 Δ in % Sales 6,773 7,150 5.6% – Continuous strong demand and faster EBITDA pre except. 447 581 30.0% implementation of Margin 6.6% 8.1% restructuring – Net Income burdened by Net Income -12 -

  12. Slide 12: Independence and Restructuring Contribute to Better Performance amid Supportive Demand

    Independence and Restructuring Contribute to Better Performance amid Supportive Demand (€ m) FY 2004 FY 2005 Δ in % Sales 6,773 7,150 6% – Price increases (+8%) and Cost of goods sold -5,349 -5,537 4% marginally stronger U.S. SG&A -1,144 -1,148 0% Dollar offset slightly lower volumes (-3%) R&D -123

  13. Slide 13: First Year of Independence: We Delivered on Promises

    First Year of Independence: We Delivered on Promises 2004 2005 Full Year Sales (€ m) 2,500 1,910 1,977 – Sales increased on risen 2,000 1,678 1,722 1,737 1,431 1,487 1,535 pricing due to higher raw 1,500 material costs, despite 1,000 500 “price-before-volume” 0 strategy being implemented Perf. Rubbe

  14. Slide 14: Performance Rubber: Leadership Turns into Value

    Performance Rubber: Leadership Turns into Value (€ m) FY 2004 FY 2005 – Sales were stronger on continued improved pricing in all BUs, clearly overcompensating Sales 1,431 1,678 the corresponding marginal volume reduction EBIT 50 108 – BTR maintains high level of profitability, Depr. / Amort. 61 63 b

  15. Slide 15: Engineering Plastics: Very Weak FIB Clouds Improvements in Remaining BUs

    Engineering Plastics: Very Weak FIB Clouds Improvements in Remaining BUs (€ m) FY 2004 FY 2005 – Sales remained flat with improved pricing in STY and SCP, offsetting lower volumes Sales 1,722 1,737 – D&A: positive 2004 adjustment to impairment in STY, impairment FIB and STY capex in 2005 EBIT 12 10

  16. Slide 16: Chemical Intermediates: Maintaining Solid Margin

    Chemical Intermediates: Maintaining Solid Margin (€ m) FY 2004 FY 2005 – Sales increase attributable mainly to BAC on Sales 1,487 1,535 the back of risen raw material prices EBIT 89 129 – EBITDA slightly better due to overall better pricing and improved cost structures Depr. / Amort. 113 82 – IPG co

  17. Slide 17: Performance Chemicals: Main Contribution to Margin Improvement by RUC and LEA

    Performance Chemicals: Main Contribution to Margin Improvement by RUC and LEA (€ m) FY 2004 FY 2005 – Slight sales increase: Price increases in all Sales 1,910 1,977 BUs, except for PAP, offset slight volume EBIT 9 118 declines, mainly in TPC and FCC Depr. / Amort. – Reduced D&A due to goodwill writ

  18. Slide 18: Financing Structure Significantly Improved while Transforming the Company

    Financing Structure Significantly Improved while Transforming the Company Net financial debt overview: (€ m) €1,135 million Net financial debt 1,200 €680 million Net financial debt 800 Long term 400 Short term Cash 0 -200 Dec. 31, 2004 Dec. 31, 2005 • Financing structure solid and long-term • Net fi

  19. Slide 19: Balance Sheet Reflects Solid Structure

    Balance Sheet Reflects Solid Structure Dec 31, Sept 30, Dec 31, Dec 31, Sept 30, Dec 31, (€ m) 2004 2005 2005 (€ m) 2004 2005 2005 Non-current Assets 1,988 1,876 1,835 Stockholders’ equity 1,365 1,422 1,256 Intangible assets 65 57 53 thereof Minority interest 14 17 17 Property, plant & equipment 1,5

  20. Slide 20: Continued Substantial Improvement in Net Debt

    Continued Substantial Improvement in Net Debt Î ~€20 m cash out for Î Longer-term debt structure rubber anti-trust (Q1) Î Lower working capital including Î Repayment of ~€30 m for payment on one-off inventory effect term adjustment with Bayer (Q2) Î Reduced net debt despite ~€50m early repayment to

  21. Slide 21: Stronger Cash Flow due to Operating Results and Improved Working Capital Management

    Stronger Cash Flow due to Operating Results and Improved Working Capital Management (€ m) FY 2004 FY 2005 – Focus on working capital and better Profit before Tax -20 -117 operating result lead to substantial improvement in operating cash flow Depreciation & Amortization 328 313 – despite ~€80 millio

  22. Slide 22: Annual Pension Review Leads to Technical Adjustment

    Annual Pension Review Leads to Technical Adjustment Changes to post-retirement benefits 1. Usual annual parameter review • Adjustment of discount rates, expected return on plan assets and expectations on pension and income development for defined benefit plans Actuarial changes: Corresponding increa

  23. Slide 23: Agenda

    Agenda 1. 2005 Business Highlights and Strategy Review 2. FY 2005 Financials 3. Strategy Update 4. Outlook April, 2006 FY 2005 Results Roadshow Chart-No. 23

  24. Slide 24: Overall Performance Still Below Average

    Overall Performance Still Below Average EBITDA* margin 2004 EBITDA* margin 2005 19.5% 20.0% 14.6% 16.0% 14.3% 13.5% 13.1% 13.5% 11.1% 10.9% 8.4% 9.8% 6.6% 8.1% ∅ ~12.5% ∅ ~13.1% Source: Annual reports Source: Annual reports * EBITDA pre exceptionals April, 2006 FY 2005 Results Roadshow Chart-No. 24

  25. Slide 25: Strategy Systematically Continued in 2006

    Strategy Systematically Continued in 2006 2006 4. Acquisitions Portfolio > 10% Portfolio 3. adjustments 9-10% Targeted 2. Performance improvement restructuring Costs - Avoid unprofitable business 1. Performance - Reduce complexity <5% improvement - Pursue initiatives to raise efficiency - Contain co

  26. Slide 26: Proportion of Profitable Sales Risen to 45%

    Proportion of Profitable Sales Risen to 45% - Margins on 55% of Business Still Inadequate Profitability split 2004 vs. 2005 EBITDA* margin €6.8 bn €7.2 bn >10% 30% Profitable share of 45% sales considerably increased 5-10% 30% 30% Unprofitable share of sales greatly <5% 40% reduced 25% 2004 2005 * E

  27. Slide 27: Continuing Focus on Restructuring

    Continuing Focus on Restructuring 2006 Targeted restructuring 4. Acquisitions - Start of Phase III Portfolio > 10% - Savings potential: ~ €50m p.a. (as of 2009) Portfolio - One-time costs: ~ €55m 3. adjustments - Reduction of up to 250 jobs 9-10% Targeted 2. Performance improvement restructuring Cos

  28. Slide 28: Phase III: €50m Annual Savings as of 2009

    Phase III: €50m Annual Savings as of 2009 Phase III: Characteristics Styrenic Resins - Optimization of production and business processes in NAFTA - Closure of unprofitable site in Camaçari/Brasil Addyston Polybutadiene Rubber Zwijndrecht - Streamlining of production processes in Orange Port-Jérôme O

  29. Slide 29: Ongoing Portfolio Management

    Ongoing Portfolio Management 2006 Acquisitions 4. Acquisitions - Not on the agenda yet Portfolio > 10% Portfolio 3. adjustments 9-10% Targeted Portfolio adjustments 2. restructuring - Continuous portfolio analysis Costs - Evaluation of all strategic options for Textile Performance Processing Chemica

  30. Slide 30: Agenda

    Agenda 1. 2005 Business Highlights and Strategy Review 2. FY 2005 Financials 3. Strategy Update 4. Outlook April, 2006 FY 2005 Results Roadshow Chart-No. 30

  31. Slide 31: Phase III: Future Savings Improve Profitability

    Phase III: Future Savings Improve Profitability Phase III (€ m) 2006e 2007e 2008e 2009e P&L Expenses -30 -15 -10 0 Cash outs -30 -15 -10 0 Headcount reduction ~140 ~70 ~40 0 Cost reduction vs. prior year 5 25 10 10 Cost reduction cumulative 5 30 40 50 EBITDA improvement vs. prior year 5 20 5 5 EBITD

  32. Slide 32: Update on Total Financial Impact due to Restructuring

    Update on Total Financial Impact due to Restructuring Phase I+II+III (€ m) 2005 2006e 2007e 2008e 2009e P&L Expenses -166 -55 -35 -25 0 Cash outs -10 -155 -90 -50 0 Headcount reduction ~540 ~610 ~470 ~40 0 Cost reduction vs. prior year 10 35 75 80 10 Cost reduction cumulative 10 45 120 200 210 EBITD

  33. Slide 33: Outlook and Reiteration of 9-10% Margin Target on the Basis of 2004 Sales

    Outlook and Reiteration of 9-10% Margin Target on the Basis of 2004 Sales Underlying assumptions – Continuous supportive economic environment in 2006 – Raw materials volatile on high level with potentially some relief on raw material prices in H2 2006 – Exchange rate €1.0 = ~USD1.25 2006 Guidance ba

  34. Slide 34: LANXESS is On Track

    LANXESS is On Track Set the Profitability increased – debt reduced pace Create Market capitalization doubled values Lay Options created for future action foundations Build Ambitious targets fully achieved confidence April, 2006 FY 2005 Results Roadshow Chart-No. 34

  35. Slide 35: Appendix

    Appendix April, 2006 FY 2005 Results Roadshow Chart-No. 35

  36. Slide 36: Sound Financing Structure

    Sound Financing Structure Main Financing Components €1,250 m Revolving Credit Facility 5-year maturity with two one-year extension options Improved terms and conditions vs. prior €1.5 bn facility Signed on October 5, 2005 €500 m Debut Eurobond Seven-year tenor, maturing on June 21, 2012 4.125% coupo

  37. Slide 37: Q4: A Year of Good Improvements Ended with a Fourth Quarter as Announced

    Q4: A Year of Good Improvements Ended with a Fourth Quarter as Announced (€ m) Q4 2004 Q4 2005 Δ in % – Price increases (+4.0%) Sales 1,726 1,786 4% and stronger U.S. Dollar Cost of goods sold -1,412 -1,431 1% (+3.2%) offset lower volumes (-3.7%) SG&A -310 -300 -3% – Further cost improvements R&D -2

  38. Slide 38: Performance Rubber: Finished the Year with a Solid Q4

    Performance Rubber: Finished the Year with a Solid Q4 (€ m) Q4 2004 Q4 2005 – Higher sales driven by strong selling price increases in all BUs due to significantly risen raw material prices, which more than Sales 385 440 offset a decline of volume EBIT 3 -3 – Profitability improvements in every BU o

  39. Slide 39: Engineering Plastics: Very Weak FIB Burdens the Segment

    Engineering Plastics: Very Weak FIB Burdens the Segment…but will Leave within Q1 2006 (€ m) Q4 2004 Q4 2005 – Slightly lower sales due to deliberate loss of volume in STY and deteriorating FIB business - reduced volume also compares to an Sales 441 434 exceptionally strong Q4 2004 in STY EBIT -8 -11

  40. Slide 40: Chemical Intermediates: Strong BAC Offset by Weaker Mix in IPG

    Chemical Intermediates: Strong BAC Offset by Weaker Mix in IPG and 2004 One-offs in FCH (€ m) Q4 2004 Q4 2005 – Price increases in BAC were counterbalanced by weaker product mix in other businesses Sales 385 367 – Lower volume due to high customer inventory EBIT 25 9 levels for certain agro products

  41. Slide 41: Performance Chemicals: Significantly Stronger Q4 Mainly due to LEA and RUC

    Performance Chemicals: Significantly Stronger Q4 Mainly due to LEA and RUC (€ m) Q4 2004 Q4 2005 – Slightly weaker pricing and product mix mainly in FCC and PAP almost offset by Sales 451 499 price increases in other BUs EBIT -5 -4 – Again improved strong contribution by RUC, LEA and MPP. LEA with p

  42. Slide 42: Focus on Working Capital Management Started to Pay Off in H2 2005

    Focus on Working Capital Management Started to Pay Off in H2 2005 % of sales**: 21.7% 24.9% 25.4% 24.0% 20.1% Total WC* – Receivables: Lower mainly on in € million: €1,468 €1,714 €1,796 €1,701 €1,439 improved payment terms 2500 – Inventories: substantial 2000 decrease, however supported 1,191 1,212

  43. Slide 43: Detailed Pension Overview

    Detailed Pension Overview Basic distinction of post-employment benefits (pensions and other post-employment benefits) Defined Contribution Plans (DC) • Amount company pays is determined • All P&L expense is at same time cash out • P&L expense is completely in functional costs • No funded status calc

  44. Slide 44: Pension Review 2005: Adjustment of Parameters for Defined Benefit Plans

    Pension Review 2005: Adjustment of Parameters for Defined Benefit Plans n Parameters for calculation of Defined Benefit Obligation (DBO) and fair value of plan assets are reviewed annually: • Discount rates to calculate present value of DBO • Expected income and pension development have to be taken

  45. Slide 45: Pension Review 2005: Shifting Bayer Retirement Fund from DB to DC

    Pension Review 2005: Shifting “Bayer Retirement Fund”* from DB to DC o German “Bayer Pensionskasse” is re-classified as “Multi-employer-plan” which results in: • Treatment as defined contribution plan as opposed to defined benefit is in accordance with IAS 19 • Costs for defined contribution plans a

  46. Slide 46: Pension Financials

    Pension Financials P&L effects (in € m) : 2004 2005 • Defined Benefit plans (Pension and other post employment benefits) 61 79 Only partly Thereof as functional costs ~42 ~51 immediate cash out Defined contribution plans* 47 81 Completely immediate (all expenses in functional costs) cash out Cash ef

  47. Slide 47: Exceptional Items Incurred in Q4 2004 and 2005

    Exceptional Items Incurred in Q4 2004 and 2005 (€ m) Q4 2004 Q4 2005 Exceptional thereof D&A Exceptional thereof D&A Performance Rubber 0 0 37 0 – “Rubber” Litigation (TRP) – Capex write-off (STY) Engin. Plastics 9 9 6 6 Chemical Intermediates 9 9 3 3 – Capex write-off (FCH) Performance Chemicals 0

  48. Slide 48: Exceptional Items Incurred in 2004 and 2005

    Exceptional Items Incurred in 2004 and 2005 (€ m) FY 2004 FY 2005 Exceptional thereof D&A Exceptional thereof D&A Performance Rubber 12 0 43 0 – “Rubber” Litigation (TRP) – 2004: Capex write-off and amendment to 2003 Engin. Plastics -3 -3 23 23 impairment; 2005: Impairment FIB and STY Capex write-of

  49. Slide 49: Restructuring: We Are Ahead of Our Plan

    Restructuring: We Are Ahead of Our Plan - in 2005 STY and FCH were Back in the Black Restructuring Achievements Phase I (initiated June 2005) − Phase II (initiated August/ September 2005) STY: − annual worktime increased − headcount being reduced − annual bonus reduced − cost savings are progressing

  50. Slide 50: Raw Materials and Currency Exposure are Managed

    Raw Materials and Currency Exposure are Managed Raw materials Currency exposure Our operating business is performed Top 10 Petrochemical Raw Materials 2005 in € m in the following major foreign currencies: US-Dollar, Yen, Pound, 1,3-Butadiene Canadian Dollar Styrene monomer Acrylonitrile Cyclohexane

  51. Slide 51: LTIP on Board Level: Stock Performance Plan and Economic Value Plan

    LTIP on Board Level: Stock Performance Plan (SPP) and Economic Value Plan (EVP) • Condition to participation: Personal investment (40% of one annual fixed salary in three tranches) • Stock Performance Plan (SPP) • Benchmark: Outperformance of the DJ global STOXX 600 Chemicals index (index+10%:100% t

  52. Slide 52: Quarterly Overview 2004/2005

    Quarterly Overview 2004/ 2005 Q1 Q2 H1 Q3 9M Q4 FY Sales 2004 2005 2004 2005 2004 2005 2004 2005 2004 2005 2004 2005 2004 2005 Perf Rubber 326 392 368 432 694 824 352 414 1046 1238 385 440 1431 1678 Eng Plastics 407 414 431 448 838 862 443 441 1281 1303 441 434 1722 1737 ChemIntermed 366 389 320 406

  53. Slide 53: Financial Calendar 2006

    Financial Calendar 2006 Full Year Results 2005 April 4, 2006 Q1 Results 2006 May 18, 2006 Q2 Results 2006 August 16, 2006 Q3 Results 2006 November 15, 2006 Annual Stockholders’ Meeting May 31, 2006 April, 2006 FY 2005 Results Roadshow Chart-No. 53

  54. Slide 54: Contact Details

    Contact Details Michael Pontzen (Head of IR) Oliver Stratmann Tel.: +49-214 30 43804 +49-214 30 49611 Fax.: +49-214 30 959 43804 +49-214 30 959 49611 Mobile: +49-175 30 43804 +49-175 30 49611 Email: Michael.Pontzen@lanxess.com Oliver.Stratmann@lanxess.com Tanja Satzer Dr. Gerd Zelesny Tel.: +49-214

Lanxess — FY2005 Earnings Presentation on 6ix